scholarly journals Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

2018 ◽  
Vol 20 (7) ◽  
pp. 1602-1614 ◽  
Author(s):  
Cristian Guja ◽  
Juan P. Frías ◽  
Aniko Somogyi ◽  
Serge Jabbour ◽  
Hui Wang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Randomized Study ◽  
Exenatide Qw

scholarly journals Open-label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin-naïve Asian patients with type 2 diabetes

2017 ◽  
Vol 9 (1) ◽  
pp. 100-107
Author(s):  
Takahisa Hirose ◽  
Zhihong Cai ◽  
Kwee Poo Yeo ◽  
Makoto Imori ◽  
Kenji Ohwaki ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Basal Insulin ◽  
Randomized Study ◽  
Open Label ◽  
Asian Patients

scholarly journals ESTIMATING THE COST TO SOCIETY FOR EXENATIDE QW AND INSULIN GLARGINE IN THE UNITED STATES FOR THE TREATMENT OF TYPE 2 DIABETES

2016 ◽  
Vol 19 (3) ◽  
pp. A201
Author(s):  
B.C. Wang ◽  
H. Nguyen ◽  
W. Furnback ◽  
G.F. Guzauskas ◽  
J. Hurd ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
The United States ◽  
Exenatide Qw ◽  
The Cost

Exenatide Versus Insulin Glargine in Patients With Suboptimally Controlled Type 2 Diabetes: A Randomized Trial

2006 ◽  
Vol 2006 ◽  
pp. 56-61
Author(s):  
J.L. Leahy ◽  
L. Kennedy
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Randomized Trial

New insulin glargine 300 U/mL: glycaemic control and hypoclycaemia in insulin-naïve people with type 2 diabetes mellitus (EDITION 3)

2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Ziemen ◽  
MC Riddle ◽  
RM Bergenstal ◽  
K Sestakauskas ◽  
H Goyeau ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycaemic Control ◽  
Insulin Glargine

The efficacy and safety of LY2963016 among patients with Type 1 and Type 2 diabetes previously treated with insulin glargine

2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
D Dahl ◽  
LB Lacaya ◽  
RK Pollom ◽  
LL Ilag ◽  
JS Zielonka
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Efficacy And Safety ◽  
Previously Treated

Switching to Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control and Reduces Nocturnal Hypoglycemia in Patients (Pts) with Type 2 Diabetes (T2DM) on Basal Insulin Supported Oral Therapy (BOT)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1020-P ◽  
Author(s):  
JOCHEN SEUFERT ◽  
ANDREAS FRITSCHE ◽  
HELMUT ANDERTEN ◽  
KATRIN PEGELOW ◽  
STEFAN PSCHERER ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Insulin Glargine ◽  
Basal Insulin ◽  
Oral Therapy ◽  
Nocturnal Hypoglycemia

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1057-P
Author(s):  
SEAN D. SULLIVAN ◽  
TIMOTHY S. BAILEY ◽  
RONAN ROUSSEL ◽  
FANG L. ZHOU ◽  
ZSOLT BOSNYAK ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Clinical Outcomes ◽  
Real World ◽  
Insulin Detemir ◽  
Insulin Degludec ◽  
Subgroup Analyses
Sign in / Sign up

Export Citation Format

Share Document